Literature DB >> 1649559

Effects of dexmedetomidine, a novel imidazole sedative-anesthetic agent, on adrenal steroidogenesis: in vivo and in vitro studies.

M Maze1, R Virtanen, D Daunt, S J Banks, E P Stover, D Feldman.   

Abstract

Inhibition of steroidogenesis may be produced perioperatively by imidazole compounds, such as the hypnotic agent etomidate, with potentially serious consequences for patient morbidity and mortality. Dexmedetomidine, ([+]4-[1-[2,3-dimethylphenyl]-ethyl]-1H-imidazole), another imidazole compound with anesthetic like properties, is now being used perioperatively. Therefore, we investigated the effects of dexmedetomidine on steroidogenesis as well as on binding to glucocorticoid receptors in a series of in vitro and in vivo animal studies. The effect of dexmedetomidine, 10(-8)-10(-3) M, on adrenocorticotrophic hormone (ACTH) stimulated release of corticosterone was assessed in isolated rat adrenal cells. To characterize dexmedetomidine interactions with the glucocorticoid receptor, dexmedetomidine's ability to compete for [3H]dexmethasone binding sites was studied in renal tubular cells. The effect of dexmedetomidine, 80 micrograms/kg subcutaneously, on ACTH-stimulated release of cortisol was studied in separate cohorts of dogs at various time intervals during and after anesthesia was given. To compare the inhibitory effects of etomidate and dexmedetomidine on steroidogenesis, ACTH-stimulated release of cortisol was studied in dogs treated with anesthetic doses of either dexmedetomidine (80 micrograms/kg IV) or etomidate (1 mg/kg IV). Finally, dogs were given dexmedetomidine by continuous subcutaneous infusion for 7 days at sedative doses after which their cortisol response to ACTH was determined. At dexmedetomidine concentrations greater than 10(-7) M, a dose-dependent inhibition of corticosterone release was detected in response to ACTH stimulation in vitro. At these high dexmedetomidine concentrations, [3H]dexamethasone binding was not affected. In the in vivo dog experiments, basal cortisol levels decreased and the cortisol response to ACTH was blunted 3 h after dexmedetomidine administration.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649559     DOI: 10.1213/00000539-199108000-00015

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  21 in total

1.  Dexmedetomidine: a novel sedative-analgesic agent.

Authors:  R Gertler; H C Brown; D H Mitchell; E N Silvius
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-01

2.  Neurohormonal and metabolic effects of medetomidine compared with xylazine in healthy cats.

Authors:  Teppei Kanda; Yoshiaki Hikasa
Journal:  Can J Vet Res       Date:  2008-04       Impact factor: 1.310

3.  Effects of Dexmedetomidine and Ketamine-Dexmedetomidine with and without Buprenorphine on Corticoadrenal Function in Rabbits.

Authors:  Alfredo González-Gil; Alberto Villa; Pilar Millán; Leticia Martínez-Fernández; Juan Carlos Illera
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-05       Impact factor: 1.232

4.  Use of α(2)-Agonists in Neuroanesthesia: An Overview.

Authors:  Ehab Farag; Maged Argalious; Daniel I Sessler; Andrea Kurz; Zeyd Y Ebrahim; Armin Schubert
Journal:  Ochsner J       Date:  2011

5.  Effects of 2 different medetomidine infusion rates on selected neurohormonal and metabolic parameters in dogs.

Authors:  Leigh Lamont; Shelley Burton; Deanne Caines; Elmabrok Masaoud; Eric Troncy
Journal:  Can J Vet Res       Date:  2012-04       Impact factor: 1.310

6.  Preventive effects of low-dose dexmedetomidine on postoperative cognitive function and recovery quality in elderly oral cancer patients.

Authors:  Yong Guo; Lulu Sun; Junfeng Zhang; Qifang Li; Hong Jiang; Wei Jiang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

7.  Neurohormonal and metabolic effects of medetomidine compared with xylazine in beagle dogs.

Authors:  T D Ambrisko; Y Hikasa
Journal:  Can J Vet Res       Date:  2002-01       Impact factor: 1.310

Review 8.  [Analgesia and sedation in intensive care medicine].

Authors:  E Schaffrath; R Kuhlen; P H Tonner
Journal:  Anaesthesist       Date:  2004-11       Impact factor: 1.041

9.  Comparative assessment of the anaesthetic and analgesic effects of intramuscular and epidural clonidine in humans.

Authors:  E Samsó; J Vallés; O Pol; L Gallart; M M Puig
Journal:  Can J Anaesth       Date:  1996-12       Impact factor: 5.063

10.  Sedative-hypnotic Binding to 11β-hydroxylase.

Authors:  Ervin Pejo; Xiaojuan Zhou; S Shaukat Husain; Douglas E Raines
Journal:  Anesthesiology       Date:  2016-11       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.